TrueScan MRI says lessons from nearly 4,000 patients in Alzheimer's research on the drug behind Ozempic suggest timing may matter most.
Recap by typeshit. Post by @truescanmri on Instagram.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
Novo Nordisk shared the figure from a post-trial analysis of its next-generation experimental drug, with results broken out for women.
Patients moved off weekly Wegovy injections onto a daily pill, and Men's Journal reports one group's weight outcomes stood out from the rest.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
A Facebook post says needle-free strip formats are moving from labs toward real use. No product, study or data is named to back it up.
10:37
PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
Loading…